There will be plenty of chance to buy in if/when the share price is confirmed to change direction. If you desire to do so.
The company has said CHM needs data from another three arms before a partnership can happen. We know one of those arms has already been hit. And the other arms have already been recruited. The binary answer to the data being good enough or not should be found in the next few months.
As a non holder who gets twitchy with risk, I would suggest you wait until that happens before thinking to buy.
The market cap does not represent the pipeline progress. We know this has been smothered by the companies financial woes.
Dr Bec has put the company in a position where it's time to either poo or get off the pot. And I like the way this has been done. In a few months, if the data provided is good enough (and so far it has been), a partnership will occur, which both derisks the financials and the drug. Only after that can we expect the market cap to move to a more appropriate level. And that will potentially be a very big move.
And then we have the rest of the pipeline.
CHM Price at posting:
0.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)